Today, disorders that affect the newborn remain a challenge for physicians because of the enigmatic pathophysiology and difficulties in treating such delicate patients. Metabolomics, the “omics” science that studies the metabolome, namely the metabolites present in biological fluids, such as saliva, blood, sweat, and breast milk in a given time or condition, can be useful in helping neonatologists to prevent, diagnose, and treat diseases affecting the neonate, especially those with higher mortality rates. Since it is a relatively new technology, studies of its application in neonatology are limited. The aims of this review are to present metabolomics data on relevant neonatal disorders and to identify and discuss the most important 5 metabolites and their clinical significance rather than focusing on each disorder. The preliminary data are promising but further studies on metab-olomics in neonatology are needed together with the standardization of results before their application in clinical practice.

Keywords:
Newborn, Metabolomics, Metabolites
1.
Marincola FC, Dessì A, Pattumelli MG, Corbu S, Ossicini C, Ciccarelli S, Agostino R, Mussap M, Fanos V: 1H-NMR-based urine metabolic profile of IUGR, LGA, and AGA newborns in the first week of life. Clin Chim Acta 2015; 451: 28–34.
2.
Dessì A, Marincola FC, Pattumelli MG, Ciccarelli S, Corbu S, Ossicini C, Fanos V, Agostino R: Investigation of the 1H-NMR based urine metabolomic profiles of IUGR, LGA and AGA newborns on the first day of life. J Matern Fetal Neonatal Med 2014; 27(suppl 2): 13–19.
3.
Dessì A, Murgia A, Agostino R, Pattumelli MG, Schirru A, Scano P, Fanos V, Caboni P: Exploring the role of different neonatal nutrition regimens during the first week of life by urinary GC-MS metabolomics. Int J Mol Sci 2016; 17: 265.
4.
Marincola FC, Corbu S, Lussu M, Noto A, Dessì A, Longo S, Civardi E, Garofoli F, Grenci B, Mongini E, Budelli A, Grinzato A, Fasano F, Fanos V, Stronati M: Impact of early postnatal nutrition on the NMR urinary metabolic profile of infant. J Proteome Res 2016; 15: 3712–3723.
5.
Dessì A, Atzori L, Noto A, Visser GH, Gazzolo D, Zanardo V, Barberini L, Puddu M, Ottonello G, Atzei A, De Magistris A, Lussu M, Murgia F, Fanos V: Metabolomics in newborns with intrauterine growth retardation (IUGR): urine reveals markers of metabolic syndrome. J Matern Fetal Neonatal Med 2011; 24(suppl 2): 35–39.
6.
Noto A, Pomero G, Mussap M, Barberini L, Fattuoni C, Palmas F, Dalmazzo C, Delogu A, Dessì A, Fanos V, Gancia P: Urinary gas chromatography mass spectrometry metabolomics in asphyxiated newborns undergoing hypothermia: from the birth to the first month of life. Ann Transl Med 2016; 4: 417.
7.
Longini M, Giglio S, Perrone S, Vivi A, Tassini M, Fanos V, Sarafidis K, Buonocore G: Proton nuclear magnetic resonance spectroscopy of urine samples in preterm asphyctic newborn: a metabolomic approach. Clin Chim Acta 2015; 444: 250–256.
8.
Fanos V, Caboni P, Corsello G, Stronati M, Gazzolo D, Noto A, Lussu M, Dessì A, Giuffrè M, Lacerenza S, Serraino F, Garofoli F, Serpero LD, Liori B, Carboni R, Atzori L: Urinary 1H-NMR and GC-MS metabolomics predicts early and late onset neonatal sepsis. Early Hum Dev 2014; 90(suppl 1):S78–S83.
9.
Dessì A, Liori B, Caboni P, Corsello G, Giuffrè M, Noto A, Serraino F, Stronati M, Zaffanello M, Fanos V: Monitoring neonatal fungal infection with metabolomics. J Matern Fetal Neonatal Med 2014; 27(suppl 2): 34–38.
10.
Palmas F, De Magistris A, Noto A, Barberini L, Fattuoni C, Dessì A, Fanos V, Picaud JC: Metabolomics study on NEC occurrence by GC-MS. Selected Abstracts of the 12th International Workshop on Neonatology, Cagliari, October 19–22, 2016. J Pediatr Neonat Individual Med 2016; 5:e050247.
11.
De Magistris A, Corbu S, Cesare Marincola F, Gueye M, Pastor-Diez B, Dessì A, Noto A, Reali A, Fanos V, Puddu M, Picaud J-C: NMR-based metabolomics analysis of urinary changes in neonatal necrotizing enterocolitis. Selected Abstracts of the 11th International Workshop on Neonatology, Cagliari, October 26–31, 2015. J Pediatr Neonat Individual Med 2015; 4:e040249.
12.
Fanos V, Pintus MC, Lussu M, Atzori L, Noto A, Stronati M, Guimaraes H, Marcialis MA, Rocha G, Moretti C, Papoff P, Lacerenza S, Puddu S, Giuffrè M, Serraino F, Mussap M, Corsello G: Urinary metabolomics of bronchopulmonary dysplasia (BPD): preliminary data at birth suggest it is a congenital disease. J Matern Fetal Neonatal Med 2014; 27(suppl 2): 39–45.
13.
Neuberger A: The metabolism of glycine and serine. Comp Biochem 1981; 19: 257–303.
14.
Jackson AA, Persaud C, Hall M, Smith S, Evans N, Rutter N: Urinary excretion of 5-L-oxoproline (pyroglutamic acid) during early life in term and preterm infants. Arch Dis Child Fetal Neonatal Ed 1997; 76:F152–F157.
15.
Gannon MC, Nuttall JA, Nuttall FQ: The metabolic response to ingested glycine. Am J Clin Nutr 2002; 76: 1302–1307.
16.
O’Donovan DJ, Fernandes CJ: Free radicals and diseases in premature infants. Antioxid Redox Signal 2004; 6: 169–176.
17.
Saugstad OD: Bronchopulmonary dysplasia-oxidative stress and antioxidants. Semin Neonatol 2003; 8: 39–49.
18.
Dani C, Cecchi A, Bertini G: Role of oxidative stress as physiopathologic factor in the preterm infant. Minerva Pediatr 2004; 56: 381–394.
19.
Njålsson R, Norgren S: Physiological and pathological aspects of GSH metabolism. Acta Paediatr 2005; 94: 132–137.
20.
Jain A, Mehta T, Auld PA, Rodrigues J, Ward RF, Schwartz MK, Marensson J: Glutathione metabolism in newborns: evidence for glutathione deficiency in plasma bronchoalveolar lavage fluid, and lymphocytes in prematures. Pediatr Pulmonol 1995; 20: 160–166.
21.
Li ST, Huang XL, Wu SG, Ma YM, Shi CC, Xiao X, Hao H: Gas chromatography-mass spectrometry based urinary metabolomics in very low birth weight premature infants (in Chinese). Zhonghua Er Ke Za Zhi 2017; 55: 434–438.
22.
Moltu SJ, Sachse D, Blakstad EW, Strømmen K, Nakstad B, Almaas AN, Westerberg AC, Rønnestad A, Brække K, Veierød MB, Iversen PO, Rise F, Berg JP, Drevon CA: Urinary metabolite profiles in premature infants show early postnatal metabolic adaptation and maturation. Nutrients 2014; 6: 1913–1930.
23.
Mabrouk GM, Jois M, Brosnan JT: Cell signalling and the hormonal stimulation of the hepatic glycine cleavage enzyme system by glucagon. Biochem J 1998; 330: 759–763.
24.
Yu YM, Ryan CM, Fei ZW, Lu XM, Castillo L, Schultz JT, Tompkins RG, Young VR: Plasma L-5-oxoproline kinetics and whole blood glutathione synthesis rates in severely burned adult humans. Am J Physiol Endocrinol Metab 2002; 282:E247-E258.
25.
Persaud C, Forrester T, Jackson A: Urinary excretion of 5-L-oxoproline (pyroglutamic acid) is increased during recovery from severe childhood malnutrition and responds to supplemental glycine. J Nutr 1996; 126: 2823–2830.
26.
Sugita O, Uchiyama K, Yamada T, Sato T, Okada M, Takeuchi K: Reference values of serum and urine creatinine, and of creatinine clearance by a new enzymatic method. Ann Clin Biochem 1992; 29: 523–528.
27.
Zeisel SH, da Costa KA: Choline: an essential nutrient for public health. Nutr Rev 2009; 67: 615–623.
28.
Kinney HC, Karthigasan J, Borenshteyn NI, Flax JD, Kirschner DA: Myelination in the developing human brain: biochemical correlates. Neurochem Res 1994; 19: 983–996.
29.
Reinke SN, Walsh BH, Boylan GB, Sykes BD, Kenny LC, Murray DM, Broadhurst DI: 1H-NMR derived metabolomic profile of neonatal asphyxia in umbilical cord serum: implications for hypoxic ischemic encephalopathy. J Proteome Res 2013; 12: 4230–4239.
30.
Rima O: The metabolic burden of methyl donor deficiency with focus on the betaine homocysteine methyltransferase pathway. Nutrients 2013; 5: 3481–3495.
31.
Deminice R, da Silva RP, Lamarre SG, Kelly KB, Jacobs RL, Brosnan ME, Brosnan JT: Betaine supplementation prevents fatty liver induced by a high-fat diet: effects on one-carbon metabolism. Amino Acids 2015; 47: 839–846.
32.
Ivorra C, García-Vicent C, Chaves FJ, Monleón D, Morales JM, Lurbe E: Metabolomic profiling in blood from umbilical cords of low birth weight newborns. J Transl Med 2012; 10: 142.
33.
Alexandre-Gouabau MC, Courant F, Moyon T, Küster A, Le Gall G, Tea I, Antignac JP, Darmaun D: Maternal and cord blood LC-HRMS metabolomics reveal alterations in energy and polyamine metabolism, and oxidative stress in very-low birth weight infants. J Proteome Res 2013; 12: 2764–2778.
34.
Sanz-Cortés M, Carbajo RJ, Crispi F, Figueras F, Pineda-Lucena A, Gratacós E: Metabolomic profile of umbilical cord blood plasma from early and late intrauterine growth restricted (IUGR) neonates with and without signs of brain vasodilation. PLoS One 2013; 8:e80121.
35.
Bernhard W, Raith M, Kunze R, Koch V, Heni M, Maas C, Abele H, Poets CF, Franz AR: Choline concentrations are lower in postnatal plasma of preterm infants than in cord plasma. Eur J Nutr 2015; 54: 733–741.
36.
Sundekilde UK, Downey E, O’Mahony JA, O’Shea CA, Ryan CA, Kelly AL, Bertram HC: The effect of gestational and lactational age on the human milk metabolome. Nutrients 2016; 8:E304.
37.
Andreas NJ, Hyde MJ, Gomez-Romero M, Lopez-Gonzalvez MA, Villaseñor A, Wijeyesekera A, Barbas C, Modi N, Holmes E, Garcia-Perez I: Multiplatform characterization of dynamic changes in breast milk during lactation. Electrophoresis 2015;36:2269–2285.
38.
Spevacek AR, Smilowitz JT, Chin EL, Underwood MA, German JB, Slupsky CM: Infant maturity at birth reveals minor differences in the maternal milk metabolome in the first month of lactation. J Nutr 2015; 145: 1698–1708.
39.
Stephens FB, Wall BT, Marimuthu K, Shannon CE, Constantin-Teodosiu D, Macdonald IA, Greenhaff PL: Skeletal muscle carnitine loading increases energy expenditure, modulates fuel metabolism gene networks and prevents body fat accumulation in humans. J Physiol 2013; 591: 4655–4666.
40.
Rohatgi N, Nielsen TK, Bjørn SP, Axelsson I, Paglia G, Voldborg BG, Palsson BO, Rolfsson Ó: Biochemical characterization of human gluconokinase and the proposed metabolic impact of gluconic acid as determined by constraint based metabolic network analysis. PLoS One 2014; 9:e98760.
41.
Entner N, Doudoroff M: Glucose and gluconic acid oxidation of Pseudomonas saccharophila. J Biol Chem 1952; 196: 853–862.
42.
Peekhaus N, Conway T: What’s for dinner?: Entner-Doudoroff metabolism in Escherichia coli. J Bacteriol 1998; 180: 3495–3502.
43.
Stewart CJ, Embleton ND, Marrs EC, Smith DP, Nelson A, Abdulkadir B, Skeath T, Petrosino JF, Perry JD, Berrington JE, Cummings SP: Temporal bacterial and metabolic development of the preterm gut reveals specific signatures in health and disease. Microbiome 2016; 4: 67.
44.
Morrow AL, Lagomarcino AJ, Schibler KR, Taft DH, Yu Z, Wang B, Altaye M, Wagner M, Gevers D, Ward DV, Kennedy MA, Huttenhower C, Newburg DS: Early microbial and metabolomic signatures predict later onset of necrotizing enterocolitis in preterm infants. Microbiome 2013; 1: 13.
45.
Dessì A, Pintus R, Marras S, Cesare Marincola F, De Magistris A, Fanos V: Metabolomics in necrotizing enterocolitis: the state of the art. Expert Rev Mol Diagn 2016; 16: 1053–1058.
46.
Fattuoni C, Pietrasanta C, Pugni L, Ronchi A, Palmas F, Barberini L, Dessì A, Pintus R, Fanos V, Noto A, Mosca F: Urinary metabolomic analysis to identify preterm neonates exposed to histological chorioamnionitis: a pilot study. PLoS One 2017; 12:e0189120.
47.
Dessì A, Fanos V: Myoinositol: a new marker of intrauterine growth restriction? J Obstet Gynaecol 2013; 33: 776–780.
48.
Ostlund RE Jr, McGill JB, Herskowitz I, Kipnis DM, Santiago JV, Sherman WR: D-Chiro-inositol metabolism in diabetes mellitus. Proc Natl Acad Sci USA 1993; 90: 9988–9992.
49.
Diaz SO, Pinto J, Barros AS, Morais E, Duarte D, Negrão F, Pita C, Almeida Mdo C, Carreira IM, Spraul M, Gil AM: Newborn urinary metabolic signatures of prematurity and other disorders: a case control study. J Proteome Res 2016; 15: 311–325.
50.
Locci E, Noto A, Puddu M, Pomero G, Dalmazzo C, Delogu A, Fanos V, d’Aloja E, Gancia P: Urinary 1H-NMR metabolomics of newborns with hypoxic-ischemic encephalopathy undergoing hypothermia therapy in the first month. PLoS One 2018, in press.
© 2018 S. Karger AG, Basel
2018
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.